Professor of Clinical Medicine
Cardiology - Fresno
Publications
Higher Risk of Kidney Failure Associated with Angiotensin Receptor Blockers Versus ACE Inhibitors in Patients with Heart Failure.
The American journal of medicine
Renin Angiotensin Inhibition and Lower Risk of Kidney Failure in Patients with Heart Failure: Subtitle: RAS inhibition and kidney failure in heart failure.
The American journal of medicine
Outcomes of KDIGO-Defined CKD in U.S. Veterans With HFpEF, HFmrEF, and HFrEF.
JACC. Heart failure
Digoxin Discontinuation in Patients with HFrEF on Beta-Blockers: Implication for Future "Knock-Out Trials" in Heart Failure.
The American journal of medicine
Global Community Health Screening and Educational Intervention for Early Detection of Cardiometabolic Renal Disease.
Annals of global health
Identification and outcomes of KDIGO-defined chronic kidney disease in 1.4 million U.S. Veterans with heart failure.
European journal of heart failure
Considerations Regarding Management of Heart Failure in Older Adults.
Cardiology in review
Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IV.
Journal of clinical lipidology
Renin-Angiotensin Inhibition and Outcomes in HFrEF and Advanced Kidney Disease.
The American journal of medicine
Risk of Stroke in Older Adults With Heart Failure.
The American journal of cardiology
Assessment of Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended.
JAMA oncology
Initiation of anti-hypertensive drugs and outcomes in patients with heart failure with preserved ejection fraction and persistent hypertension.
Progress in cardiovascular diseases
GLP-1 receptor agonists and cardiovascular outcomes in patients with type 2 diabetes: Clinical evidence and best practice.
Journal of the American Association of Nurse Practitioners
In-Hospital Weight Loss and Outcomes in Patients With Heart Failure.
Journal of cardiac failure
Cardiovascular Impact of Race and Ethnicity in Patients With Diabetes and Obesity: JACC Focus Seminar 2/9.
Journal of the American College of Cardiology
Beta-Blocker Use and Outcomes in Nursing Home Residents with Heart Failure with Reduced Ejection Fraction.
The American journal of medicine
Initiation of Anti-Hypertensive Drugs and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction.
The American journal of medicine
SGLT2 Inhibitors: The Dawn of a New Era in Cardio-Metabolic Therapeutics.
American journal of cardiovascular drugs : drugs, devices, and other interventions
Right Ventricular Ejection Fraction and Beta-Blocker Effect in Heart Failure With Reduced Ejection Fraction.
Journal of cardiac failure
Income disparity and incident cardiovascular disease in older Americans.
Progress in cardiovascular diseases
A Comprehensive Cardiovascular-Renal-Metabolic Risk Reduction Approach to Patients with Type 2 Diabetes Mellitus.
The American journal of medicine
Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects - A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial.
Circulation journal : official journal of the Japanese Circulation Society
Loop Diuretic Prescription and Long-Term Outcomes in Heart Failure: Association Modification by Congestion.
The American journal of medicine
Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes.
American journal of cardiovascular drugs : drugs, devices, and other interventions
Defining the Role of Icosapent Ethyl in Clinical Practice.
American journal of cardiovascular drugs : drugs, devices, and other interventions
Impact of the 2017 ACC/AHA guidelines on the prevalence of hypertension among Indian adults: Results from a cross-sectional survey.
International Journal of Cardiology. Hypertension
Systolic Blood Pressure and Outcomes in Older Patients with HFpEF and Hypertension.
The American journal of medicine
Evidence-Based Policy Making for Public Health Interventions in Cardiovascular Diseases: Formally Assessing the Feasibility of Clinical Trials.
Circulation. Cardiovascular quality and outcomes
Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure.
Journal of the American College of Cardiology
Digoxin Initiation and Outcomes in Patients with Heart Failure (HFrEF and HFpEF) and Atrial Fibrillation.
The American journal of medicine
Association between depression and readmission of heart failure: A national representative database study.
Progress in cardiovascular diseases
Aspirin for Primary Prevention of Coronary Artery Disease.
Current problems in cardiology
Therapeutic Inertia in Cardiovascular Disease Prevention: Time to Move the Bar.
Journal of the American College of Cardiology
Prevalence of hypertension among Indian adults: Results from the great India blood pressure survey.
Indian heart journal
Sodium Glucose Co-transporter 2 Inhibitors and Heart Failure.
The American journal of cardiology
Emerging strategies for diabetes and cardiovascular disorders: Introduction and foreword.
Progress in cardiovascular diseases
Trends of Cardiac Complications in Patients With Rheumatoid Arthritis: Analysis of the United States National Inpatient Sample; 2005-2014.
Current problems in cardiology
Cardiovascular outcome trials of the newer anti-diabetic medications.
Progress in cardiovascular diseases
An update on pharmacotherapies in diabetic dyslipidemia.
Progress in cardiovascular diseases
Oral insulin: an update.
Minerva endocrinologica
Alirocumab efficacy and safety by race and ethnicity: Analysis from 3 ODYSSEY phase 3 trials.
Journal of clinical lipidology
Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial.
Journal of the American College of Cardiology
Cardiovascular Protection with Anti-hyperglycemic Agents.
American journal of cardiovascular drugs : drugs, devices, and other interventions
Cardiometabolic-Renal Disease in South Asians: Consensus Recommendations from the Cardio Renal Society of America.
Cardiorenal medicine
Fish Oil and Cardiometabolic Diseases: Recent Updates and Controversies.
The American journal of medicine
The Ongoing Saga of Optimal Blood Pressure Level in Patients With Diabetes Mellitus and Coronary Artery Disease.
Journal of the American Heart Association
Dangers of Hypoglycemia in Cardiac Patients With Diabetes: Time to Switch to Safer, Newer Drugs.
Journal of the American College of Cardiology
American Heart Association Diabetes and Cardiometabolic Health Summit: Summary and Recommendations.
Journal of the American Heart Association
Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate.
The American journal of medicine
SGLT-2 Inhibitors and Peripheral Artery Disease: A Statistical Hoax or Reality?
Current problems in cardiology
Obesity is rarely healthy.
The lancet. Diabetes & endocrinology
Dangers and Long-Term Outcomes in Metabolically Healthy Obesity: The Impact of the Missing Fitness Component.
Journal of the American College of Cardiology
Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.
JAMA cardiology
25-Year trends in hypertension prevalence, awareness, treatment, and control in an Indian urban population: Jaipur Heart Watch.
Indian heart journal
Olmesartan-based monotherapy vs combination therapy in hypertension: A meta-analysis based on age and chronic kidney disease status.
Journal of clinical hypertension (Greenwich, Conn.)
Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.
Journal of the American College of Cardiology
Hearty Breakfast for Healthier Arteries.
Journal of the American College of Cardiology
Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial.
European journal of heart failure
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial.
The lancet. Diabetes & endocrinology
Treatment of systolic hypertension and low diastolic blood pressure in older adults: How low is too low?!
International journal of cardiology
Digoxin and 30-Day All-Cause Readmission in Long-Term Care Residents Hospitalized for Heart Failure.
Journal of the American Medical Directors Association
Corrigendum to "Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the cardiovascular health study" [Int. J. Cardiol. 235 (2017) 11-16].
International journal of cardiology
Updated risk factors should be used to predict development of diabetes.
Journal of diabetes and its complications
Isolated diastolic hypertension and incident heart failure in community-dwelling older adults: Insights from the Cardiovascular Health Study.
International journal of cardiology
Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the Cardiovascular Health Study.
International journal of cardiology
Anticoagulation in Atrial Fibrillation: Is the Paradigm Really Shifting?
Journal of the American College of Cardiology
Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactone.
International journal of cardiology
Management of Dyslipidemia in Patients with Hypertension, Diabetes, and Metabolic Syndrome.
Current hypertension reports
Benefits of Heart Rate Slowing With Ivabradine in Patients With Systolic Heart Failure and Coronary Artery Disease.
The American journal of cardiology
Differing predictive relationships between baseline LDL-C, systolic blood pressure, and cardiovascular outcomes.
International journal of cardiology
Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure.
The American journal of medicine
Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure.
The American journal of medicine
Mechanical Circulatory Support and Rationale for Future Research-Reply.
JAMA internal medicine
Relation Between Change in Renal Function and Cardiovascular Outcomes in Atorvastatin-Treated Patients (from the Treating to New Targets [TNT] Study).
The American journal of cardiology
Effect of high-dose atorvastatin on the cardiovascular risk associated with individual components of metabolic syndrome: a subanalysis of the Treating to New Targets (TNT) study.
Diabetes, obesity & metabolism
Is Increased Use of Mechanical Circulatory Support Devices Justified? A Cause for Concern.
JAMA internal medicine
The safety and tolerability of beta blockers in heart failure with reduced ejection fraction: is the current underutilization of this evidence-based therapy justified?
Expert opinion on drug safety
Frequent Atrial Premature Complexes and Their Association With Risk of Atrial Fibrillation.
The American journal of cardiology
Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes: Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology.
Journal of the American College of Cardiology
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2.
Journal of clinical lipidology
Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial.
European journal of heart failure
Risk of Heart Failure and Death After Prolonged Smoking Cessation: Role of Amount and Duration of Prior Smoking.
Circulation. Heart failure
Geographic epidemiology of cardiometabolic risk factors in middle class urban residents in India: cross-sectional study.
Journal of global health
Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation.
The International journal of angiology : official publication of the International College of Angiology, Inc
An evidence-based review of edoxaban and its role in stroke prevention in patients with nonvalvular atrial fibrillation.
Core evidence
Low Prevalence of AHA-Defined Ideal Cardiovascular Health Factors: A Study of Urban Indian Men and Women.
Global heart
Gaps in guideline implementation: a cause for concern, time for action.
Journal of the American College of Cardiology
Management of Patients With Stable Angina and Type 2 Diabetes.
Reviews in cardiovascular medicine
Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure.
The American journal of medicine
Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the Veterans Affairs versus other hospitals: insights from the Beta-blocker Evaluation of Survival Trial (BEST).
Circulation. Heart failure
Prevalence of diabetes and cardiovascular risk factors in middle-class urban participants in India.
BMJ open diabetes research & care
Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease.
The American journal of medicine
Reply: To PMID 24846806.
The American journal of cardiology
Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease.
The American journal of medicine
Calcium channel blockers and outcomes in older patients with heart failure and preserved ejection fraction.
Circulation. Heart failure
Racial differences in mortality in patients with advanced systolic heart failure: potential role of right ventricular ejection fraction.
International journal of cardiology
Impact of atrial fibrillation and heart failure, independent of each other and in combination, on mortality in community-dwelling older adults.
The American journal of cardiology
High prevalence of metabolic syndrome among urban subjects in India: a multisite study.
Diabetes & metabolic syndrome
Spironolactone use and higher hospital readmission for Medicare beneficiaries with heart failure, left ventricular ejection fraction <45%, and estimated glomerular filtration rate <45 ml/min/1.73 m(2.).
The American journal of cardiology
Cholesterol lipoproteins and prevalence of dyslipidemias in urban Asian Indians: a cross sectional study.
Indian heart journal
Statins in chronic kidney disease: cardiovascular risk and kidney function.
Postgraduate medicine
Medical treatment of hypertension in patients with heart failure with preserved ejection fraction.
Current cardiology reports
Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure.
The American journal of medicine
Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease.
The American journal of medicine
Lipid lowering in patients with treatment-resistant hypertension: an analysis from the Treating to New Targets (TNT) trial.
European heart journal
Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: findings from a population-based cohort study.
International journal of cardiology
A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk.
The American journal of cardiology
Diabetes, cardiovascular disease, and ethnicity.
Journal of the American College of Cardiology
Primary Prevention of Atrial Fibrillation - The Path Untread.
Journal of atrial fibrillation
Effects of add-on nebivolol on blood pressure and glucose parameters in hypertensive patients with prediabetes.
Journal of clinical hypertension (Greenwich, Conn.)
New oral anticoagulants in elderly patients with atrial fibrillation.
The American journal of medicine
Normotension, prehypertension, and hypertension in urban middle-class subjects in India: prevalence, awareness, treatment, and control.
American journal of hypertension
Ivabradine in heart failure: hope or hype?
American journal of cardiovascular drugs : drugs, devices, and other interventions
Prediabetes and the risk of diabetes.
Lancet (London, England)
β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
JAMA
Evidence-based therapy for heart failure.
The Medical clinics of North America
Heart failure: a common and complex clinical syndrome.
The Medical clinics of North America
The epidemiology and pathophysiology of heart failure.
The Medical clinics of North America
Atrial fibrillation in heart failure.
The Medical clinics of North America
An evidence-based review of apixaban and its potential in the prevention of stroke in patients with atrial fibrillation.
Core evidence
Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide?
Journal of clinical hypertension (Greenwich, Conn.)
Regional variations in cardiovascular risk factors in India: India heart watch.
World journal of cardiology
Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the Treating to New Targets [TNT] study).
The American journal of cardiology
Care and outcomes of Asian-American acute myocardial infarction patients: findings from the American Heart Association Get With The Guidelines-Coronary Artery Disease program.
Circulation. Cardiovascular quality and outcomes
An update on antithrombotic therapy in atrial fibrillation: the role of newer and emergent drugs.
Reviews in cardiovascular medicine
Polymorphisms and noncardioembolic stroke in three case-control studies.
Cerebrovascular diseases (Basel, Switzerland)
The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies.
Circulation. Cardiovascular genetics
Twenty-year trends in cardiovascular risk factors in India and influence of educational status.
European journal of preventive cardiology
A propensity-matched study of the association of diabetes mellitus with incident heart failure and mortality among community-dwelling older adults.
The American journal of cardiology
ACP Journal Club. Review: rosiglitazone increases risk for cardiovascular outcomes and mortality compared with pioglitazone in type 2 diabetes.
Annals of internal medicine
Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina.
The American journal of medicine
Relation of increased prebeta-1 high-density lipoprotein levels to risk of coronary heart disease.
The American journal of cardiology
Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation.
American journal of cardiovascular drugs : drugs, devices, and other interventions
Reduced right ventricular ejection fraction and increased mortality in chronic systolic heart failure patients receiving β-blockers: insights from the BEST trial.
International journal of cardiology
Blood pressure control in diabetes mellitus: is lower always better, and how low should it go?
Circulation
Right ventricular ejection fraction <20% is an independent predictor of mortality but not of hospitalization in older systolic heart failure patients.
International journal of cardiology
Endothelium-dependent vasodilation is impaired in healthy offspring of hypertensive parents.
Indian heart journal
Impact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failure.
European journal of heart failure
Risk of new-onset diabetes mellitus associated with beta-blocker treatment for hypertension.
Current medical research and opinion
Relation of baseline systolic blood pressure and long-term outcomes in ambulatory patients with chronic mild to moderate heart failure.
The American journal of cardiology
Interventions for cardiovascular disease prevention.
Cardiology clinics
Lipid-lowering therapy with statins for the primary and secondary prevention of cardiovascular disease.
Cardiology clinics
Preface cardiovascular disease prevention: the continuum of primary and secondary prevention.
Cardiology clinics
Primary and secondary prevention strategy for cardiovascular disease in diabetes mellitus.
Cardiology clinics
Role of medical versus interventional strategies to prevent coronary events in patients with stable coronary artery disease.
Cardiology clinics
The anti-ischemic and anti-anginal properties of statins.
Current atherosclerosis reports
Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: An analysis of 65,396 hospitalizations from 344 hospita participating in Get With The Guidelines (GWTG).
American heart journal
Rheumatic heart disease and risk of incident heart failure among community-dwelling older adults: a prospective cohort study.
Annals of medicine
Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkers.
Journal of the American College of Cardiology
Warfarin use and outcomes in patients with advanced chronic systolic heart failure without atrial fibrillation, prior thromboembolic events, or prosthetic valves.
The American journal of cardiology
Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospitals participating in Get With The Guidelines (GWTG).
American heart journal
Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating β-blockers.
Journal of clinical hypertension (Greenwich, Conn.)
The role of renin-angiotensin agents in altering the natural history of type 2 diabetes mellitus.
Current cardiology reports
Low high-density lipoprotein cholesterol: current status and future strategies for management.
Vascular health and risk management
Outcomes in younger and older adults with chronic advanced systolic heart failure: a propensity-matched study.
International journal of cardiology
Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study.
European journal of heart failure
Benefits of statin therapy and compliance in high risk cardiovascular patients.
Vascular health and risk management
Risk of diabetes and cardiovascular disease: best to return back to the basics: comment on "Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus".
Archives of internal medicine
Hypertension as a cardiometabolic risk.
Indian heart journal
Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives.
Journal of hypertension
Impact of baseline systolic blood pressure on long-term outcomes in patients with advanced chronic systolic heart failure (insights from the BEST trial).
The American journal of cardiology
Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial).
The American journal of cardiology
Effect of nateglinide on the incidence of diabetes and cardiovascular events.
The New England journal of medicine
Effect of valsartan on the incidence of diabetes and cardiovascular events.
The New England journal of medicine
Atrial fibrillation in heart failure: a comprehensive review.
The American journal of medicine
The current state of beta blockers in hypertension therapy.
Indian heart journal
New York Heart Association functional class influences the impact of diabetes on cardiac autonomic function.
Journal of electrocardiology
Comparison of 80 versus 10 mg of atorvastatin on occurrence of cardiovascular events after the first event (from the Treating to New Targets [TNT] trial).
The American journal of cardiology
Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population.
Diabetic medicine : a journal of the British Diabetic Association
Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India.
Vascular health and risk management
Low high-density lipoprotein cholesterol and increased cardiovascular disease risk: an analysis of statin clinical trials.
The American journal of cardiology
An overview of glycemic control in the coronary care unit with recommendations for clinical management.
Journal of diabetes science and technology
Beta-adrenergic blockers for chronic heart failure.
Cardiology in review
Reducing morbidity and mortality in high risk patients with statins.
Vascular health and risk management
Usefulness of abnormal heart rate turbulence to predict cardiovascular mortality in high-risk patients with acute myocardial infarction and left ventricular dysfunction (from the EPHESUS study).
The American journal of cardiology
Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension: results of the Extended-Release Carvedilol Lipid Trial.
Journal of the American Society of Hypertension : JASH
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology
Journal of the American College of Cardiology
Contemporary approaches for cardiovascular risk reduction in diabetes.
Indian heart journal
Getting with the ACC/AHA guidelines for the treatment of chronic angina as a disease state.
Reviews in cardiovascular medicine
Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome.
Journal of clinical hypertension (Greenwich, Conn.)
Angiotensin receptor blockers: novel role in high-risk patients.
Cardiology clinics
Statins in heart failure.
Cardiology clinics
Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines.
American heart journal
The endocannabinoid system and cardiometabolic risk: effects of CB1 receptor blockade on lipid metabolism.
International journal of cardiology
Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET?
The American journal of cardiology
Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease.
Mayo Clinic proceedings
Ambulatory ECG-based T-wave alternans predicts sudden cardiac death in high-risk post-MI patients with left ventricular dysfunction in the EPHESUS study.
Journal of cardiovascular electrophysiology
Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment.
Circulation
Expanding roles for atorvastatin.
Drugs of today (Barcelona, Spain : 1998)
The benefits of intensive lipid lowering in patients with stable coronary heart disease with normal or high systolic blood pressure: an analysis of the Treating to New Targets (TNT) study.
Journal of clinical hypertension (Greenwich, Conn.)
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study.
Journal of the American College of Cardiology
Diabetes and vascular disease.
Expert review of cardiovascular therapy
Obesity is major determinant of coronary risk factors in India: Jaipur Heart Watch studies.
Indian heart journal
2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to devel
Journal of the American College of Cardiology
Evolving treatment options for prevention of cardiovascular events in high-risk hypertensive patients.
Journal of clinical hypertension (Greenwich, Conn.)
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study.
Clinical journal of the American Society of Nephrology : CJASN
Management of coronary artery disease in patients with type 2 diabetes mellitus.
Current cardiology reports
Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS Trial).
The American journal of cardiology
Clinical efficacy and cost-effectiveness of rosuvastatin.
Expert review of pharmacoeconomics & outcomes research
Trials and tribulations associated with angina and traditional therapeutic approaches.
Clinical cardiology
Diastolic dysfunction and autonomic abnormalities in patients with systolic heart failure.
European journal of heart failure
Management issues in the metabolic syndrome.
The Journal of the Association of Physicians of India
Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study.
Lancet (London, England)
Angiotensin receptor blockers: Cardiovascular protection in the metabolic syndrome.
Journal of the renin-angiotensin-aldosterone system : JRAAS
Improving outcomes in post-acute myocardial infarction heart failure: incorporation of aldosterone blockade into combination therapy to optimize neurohormonal blockade.
The American journal of cardiology
Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II).
Journal of the cardiometabolic syndrome
Dyslipidemia in special populations: Asian Indians, African Americans, and Hispanics.
Current atherosclerosis reports
Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.
Journal of cardiac failure
Coronary artery disease in South Asians: evolving strategies for treatment and prevention.
Indian heart journal
Avoid the rush to judgment in acute coronary syndromes.
Postgraduate medicine
Bedside evaluation of cardiac markers. Point-of-care testing can differentiate acute coronary syndromes.
Postgraduate medicine
Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm.
The American journal of medicine
Treating non-ST-segment elevation ACS. Pros and cons of current strategies.
Postgraduate medicine
Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.
The American journal of cardiology
Intensive lipid-lowering is no more effective than diet and low-dose lovastatin for reducing ischaemia in people with heart disease. Commentary.
Evidence-based cardiovascular medicine
Comprehensive risk reduction of cardiovascular risk factors in the diabetic patient: an integrated approach.
Cardiology clinics
Current Treatment Options for the Metabolic Syndrome.
Current treatment options in cardiovascular medicine
Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy.
Cardiology clinics
Dyslipidemia and lipid-lowering therapy in the elderly.
Expert review of cardiovascular therapy
The renin angiotensin system as a therapeutic target to prevent diabetes and its complications.
Cardiology clinics
Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome.
The American journal of cardiology
What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).
Journal of the American College of Cardiology
Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.
American heart journal
Consistency of the beneficial effect of metoprolol succinate extended release across a wide range dose of angiotensin-converting enzyme inhibitors and digitalis.
Journal of cardiac failure
Effect of aggressive versus moderate lipid-lowering therapy on myocardial ischemia: the rationale, design, and baseline characteristics of the Study Assessing Goals in the Elderly (SAGE).
American heart journal
Diabetes is a vascular disease: the role of endothelial dysfunction in pathophysiology of cardiovascular disease in diabetes.
Cardiology clinics
Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications.
Cardiology clinics
Prevalence of metabolic syndrome in an Indian urban population.
International journal of cardiology
Treating dyslipidemia in high-risk patients: case reviews and discussion.
Postgraduate medicine
Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure.
European heart journal
Effects of lipid-altering treatment in diabetes mellitus and the metabolic syndrome.
The American journal of cardiology
A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS.
Journal of cardiac failure
The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial.
Journal of the American College of Cardiology
How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).
Cardiac electrophysiology review
Metoprolol CR/XL in black patients with heart failure (from the Metoprolol CR/XL randomized intervention trial in chronic heart failure).
The American journal of cardiology
Increased variance in blood pressure distribution and changing hypertension prevalence in an urban Indian population.
Journal of human hypertension
Mechanisms of endothelial dysfunction in the metabolic syndrome.
Current diabetes reports
The rational use of diuretics in heart failure.
Current cardiology reports
The key to unraveling the mystery of mortality in heart failure: an integrated approach.
Circulation
ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients
Journal of the American College of Cardiology
Diabetes and vascular disease: common links in the emerging epidemic of coronary artery disease.
The American journal of cardiology
Heart failure in the elderly: is beta-blockade the standard of care?
Postgraduate medicine
Is alternate daily dose of atorvastatin effective in treating patients with hyperlipidemia? The Alternate Day Versus Daily Dosing of Atorvastatin Study (ADDAS).
American heart journal
Prevention of and medical therapy for atrial arrhythmias in heart failure.
Heart failure reviews
Treating hypertension in patients with diabetes.
The Nurse practitioner
Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory.
Journal of the American College of Cardiology
Expanding the outcomes in clinical trials of heart failure: the quality of life and economic components of EPHESUS (EPlerenone's neuroHormonal Efficacy and SUrvival Study).
American heart journal
The changing face of hypertension: is systolic blood pressure the final answer?
Archives of internal medicine
Pharmacotherapy in congestive heart failure: diuretic resistance and strategies to overcome resistance in patients with congestive heart failure.
Congestive heart failure (Greenwich, Conn.)
Clinical significance of cardiovascular dysmetabolic syndrome.
Current controlled trials in cardiovascular medicine
Ambulatory electrocardiographic monitoring for myocardial ischemia.
Current problems in cardiology
Pharmacotherapy of hypertension in patients with diabetes mellitus.
Expert opinion on pharmacotherapy
Global risk assessment in the presymptomatic patient.
The American journal of cardiology
Fractal and complexity measures of heart rate dynamics after acute myocardial infarction.
The American journal of cardiology
Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
American heart journal
Silent ischemia predicts poor outcome in high-risk healthy men.
Journal of the American College of Cardiology
Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function.
Journal of cardiovascular pharmacology and therapeutics
Atrial fibrillation in patients with heart failure: pharmacologic options.
Congestive heart failure (Greenwich, Conn.)
Coronary heart disease and risk factors in Asian Indians.
Advances in experimental medicine and biology
Mechanism of the deadly quartet.
The Canadian journal of cardiology
Hypertension and diabetes: new therapeutic options.
Archives of internal medicine
Silent myocardial ischaemia in the elderly.
Drugs & aging
Felodipine improves left ventricular emptying in patients with chronic heart failure: V-HeFT III echocardiographic substudy of multicenter reproducibility and detecting functional change.
Journal of cardiac failure
Endothelium: a new target for cardiovascular therapeutics.
Journal of the American College of Cardiology
ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collab
Journal of the American College of Cardiology
Pharmacotherapy in congestive heart failure: Do NSAIDs attenuate the therapeutic effect of ACE inhibitors in heart failure patients?
Congestive heart failure (Greenwich, Conn.)
Effects of L-arginine on atherogenesis and endothelial dysfunction due to secondhand smoke.
Hypertension (Dallas, Tex. : 1979)
Comparative effects of candesartan cilexetil and losartan in patients with systemic hypertension. Candesartan Versus Losartan Efficacy Comparison (CANDLE) Study Group.
Heart disease (Hagerstown, Md.)
Anti-ischemic effects of amlodipine in patients with stable angina pectoris and myocardial ischemia during daily life. Amlodipine Study Group.
The American journal of cardiology
Endothelin, the bad actor in the play: a marker or mediator of cardiovascular disease.
Journal of the American College of Cardiology
Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
The American journal of cardiology
In-utero and neonatal exposure to secondhand smoke causes vascular dysfunction in newborn rats.
Journal of the American College of Cardiology
Tophaceous pseudogout of the mitral valve.
The Annals of thoracic surgery
A perspective on hyperlipidemia: concepts of management in the prevention of coronary artery disease.
The American journal of medicine
The American College of Physicians guidelines for screening blood cholesterol levels: a commentary.
The American journal of medicine
The cardiovascular dysmetabolic syndrome.
The American journal of medicine
The deadly quartet revisited.
The American journal of medicine
Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators.
The New England journal of medicine
Antioxidant diet preserves endothelium-dependent vasodilatation in resistance arteries of hypercholesterolemic rabbits exposed to environmental tobacco smoke.
Journal of cardiovascular pharmacology
Design and baseline characteristics of the Veterans Affairs Non-Q-Wave Infarction Strategies In-Hospital (VANQWISH) trial. VANQWISH Trial Research Investigators.
Journal of the American College of Cardiology
Effects of second-hand smoke and gender on infarct size of young rats exposed in utero and in the neonatal to adolescent period.
Journal of the American College of Cardiology
Underutilization of evidence-based therapy in heart failure. An opportunity to deal a winning hand with ace up your sleeve.
Archives of internal medicine
Role of beta blockade in the treatment of myocardial ischemia.
The American journal of cardiology
The progression from hypertension to heart failure.
American journal of hypertension
Lipoprotein(a) in patients who have non-insulin-dependent diabetes with and without coronary artery disease.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Effect of morning versus evening dosing of diltiazem on myocardial ischemia detected by ambulatory electrocardiographic monitoring in chronic stable angina pectoris. Dilacor XR Ambulatory Ischemia Study Group.
The American journal of cardiology
Pulmonary effect of amiodarone in patients with heart failure. The Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy (CHF-STAT) Investigators (Veterans Affairs Cooperative Study No. 320).
Journal of the American College of Cardiology
Chronic dietary L-arginine prevents endothelial dysfunction secondary to environmental tobacco smoke in normocholesterolemic rabbits.
Hypertension (Dallas, Tex. : 1979)
Clinical relevance of ischemia induced by mental stress.
Clinical cardiology
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
Lancet (London, England)
Testosterone worsens endothelial dysfunction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta.
Journal of the American College of Cardiology
Evidence-based, cost-effective risk stratification and management after myocardial infarction. California Cardiology Working Group on Post-MI Management.
Archives of internal medicine
Silent ischaemia: to treat or not to treat?
Indian heart journal
Hemodynamic changes as triggers of cardiovascular events.
Cardiology clinics
Anti-ischemic properties of ACE-inhibitors.
Cardiologia (Rome, Italy)
Hemodynamic variability and myocardial ischemia.
Cardiology clinics
Clinical perspectives on primary and secondary prevention of coronary atherosclerosis.
The Medical clinics of North America
Contemporary approaches in medical management of patients with stable coronary artery disease.
The Medical clinics of North America
Early intervention in patients with heart failure and left ventricular dysfunction.
The Medical clinics of North America
Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.
The New England journal of medicine
Mental stress, pain perception and risk of silent ischemia.
Journal of the American College of Cardiology
Randomized Placebo-Controlled Withdrawal Study of Amlodipine in Agina Pectoris.
American journal of therapeutics
The need for a cost-effective strategy to detect ambulatory silent ischemia.
The American journal of cardiology
Triggers and timing of coronary events and sudden cardiac death.
Journal of the American College of Cardiology
Is there evidence in support of the ischemia suppression hypothesis?
Journal of the American College of Cardiology
Should asymptomatic subjects with silent ischemia undergo further evaluation and follow-up?
International journal of cardiology
Comparison of the prognostic values of ischemia during daily life and ischemia induced by treadmill exercise testing.
The American journal of cardiology
Predictors of mortality in patients with heart failure.
Cardiology clinics
Prevalence and prognosis of heart failure.
Cardiology clinics
Prevention of heart failure and postinfarction remodeling.
Cardiology clinics
Ventricular arrhythmias in heart failure: to treat or not to treat?
Cardiology clinics
Does myocardial ischemia portend poor prognosis?
Journal of the American College of Cardiology
Information integration in a decision support system.
Proceedings. Symposium on Computer Applications in Medical Care
Veterans Affairs congestive heart failure antiarrhythmic trial. CHF STAT Investigators.
The American journal of cardiology
Amlodipine once a day in stable angina: double-blind crossover comparison with placebo.
Clinical cardiology
Asymptomatic ischemia during predischarge Holter monitoring predicts poor prognosis in the postinfarction period.
The American journal of cardiology
Secondary prevention after myocardial infarction. Too many choices, which ones work?
Archives of internal medicine
Diagnostic and therapeutic implications: exploration through case discussions.
The American journal of cardiology
Role of myocardial oxygen demand in the pathogenesis of silent ischemia during daily life.
The American journal of cardiology
The Council for Myocardial Ischemia and Infarction: advisory group reports on silent myocardial ischemia, heart rate control, and post-myocardial infarction management.
The American journal of cardiology
Increased myocardial oxygen demand and ischemia during daily life: resurrection of an age-old concept.
Journal of the American College of Cardiology
Congestive heart failure: survival trial of antiarrhythmic therapy (CHF STAT). The CHF STAT Investigators.
Controlled clinical trials
Ambulatory electrocardiography evaluation of asymptomatic, unstable, and stable coronary artery disease patients for myocardial ischemia.
Cardiology clinics
Systemic and coronary hemodynamic effects of bepridil in patients with depressed left ventricular function.
The American journal of cardiology
Silent myocardial ischemia. A clinical perspective.
Archives of internal medicine
Usefulness of ambulatory silent myocardial ischemia added to the prognostic value of exercise test parameters in predicting risk of cardiac death in patients with stable angina pectoris and exercise-induced myocardial ischemia.
The American journal of cardiology
The prognostic and economic implications of a strategy to detect and treat asymptomatic ischemia: the Atenolol Silent Ischemia Trial (ASIST) protocol.
Clinical cardiology
Anti-ischemic effects of atenolol versus nifedipine in patients with coronary artery disease and ambulatory silent ischemia.
Journal of the American College of Cardiology
Exercise test predictors of ambulatory silent ischemia during daily life in stable angina pectoris.
The American journal of cardiology
Transient myocardial ischemia and its relation to determinants of myocardial oxygen demand.
The American journal of cardiology
Angiotensin-converting enzyme inhibitors in congestive heart failure.
Archives of internal medicine
Prevalence and patterns of silent myocardial ischemia during daily life in stable angina patients receiving conventional antianginal drug therapy.
The American journal of cardiology
Silent ischemia during daily life is an independent predictor of mortality in stable angina.
Circulation
Suppressant effects of conventional beta blockers and sotalol on complex and repetitive ventricular premature complexes.
The American journal of cardiology
Is silent myocardial ischemia clinically important? Does it have prognostic significance?
Postgraduate medicine
Double-blind crossover comparison of amlodipine at three dose levels and placebo in chronic stable angina.
American heart journal
Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group.
Journal of the American College of Cardiology
Effects of beta-adrenergic stimulation on atrial latency and atrial vulnerability in patients with paroxysmal supraventricular tachycardia.
The American journal of cardiology
Electrophysiologic studies in cardiac arrhythmia. When and why they are useful.
Postgraduate medicine
Significance of arrhythmias in congestive heart failure.
Postgraduate medicine
Similar efficacy of nitrendipine in young and elderly hypertensive patients.
The American journal of cardiology
Beta blockers in combination with class I antiarrhythmic agents.
The American journal of cardiology
Current perspectives in treatment of angina pectoris.
Postgraduate medicine
Efficacy and safety comparison of nitrendipine and hydralazine as antihypertensive monotherapy.
Journal of cardiovascular pharmacology
Calcium channel blockers.
The Western journal of medicine
Effect of age on atrioventricular conduction in patients with chronic bifascicular block.
The American journal of cardiology
Chronic intraventricular conduction defects.
Indian heart journal: teaching series
Significance of fascicular block complicating acute myocardial infarction.
Indian heart journal: teaching series
Electrophysiologic observations in a patient with bradycardia-dependent atrioventricular block.
The American journal of cardiology
Sites of conduction disease in aortic stenosis: significance of valve gradient and calcification.
Annals of internal medicine
A new approach for indirect recording of anterior left atrial activation in man.
American heart journal